Management of Hemorrhagic Cerebrovascular Accident (CVA)
Patients with hemorrhagic stroke require immediate medical emergency treatment with rapid blood pressure control to systolic 140 mmHg (if presenting between 150-220 mmHg), urgent reversal of any anticoagulation, neurosurgical consultation, and intensive care unit monitoring with specialized stroke unit care. 1
Immediate Assessment and Stabilization
- Treat as a medical emergency with immediate evaluation by physicians experienced in hyperacute stroke management 1
- Perform rapid ABC assessment (airway, breathing, circulation) upon arrival 1
- Complete neurological examination using NIHSS to quantify stroke severity and guide treatment decisions 1
- Obtain non-contrast CT head within 30 minutes of hospital admission to confirm diagnosis, location, and extent of hemorrhage 1
- Urgent blood work must include complete blood count, coagulation status (INR, aPTT), and glucose 1
- Obtain detailed medication history, specifically regarding anticoagulant and antiplatelet therapy 1
Blood Pressure Management
For patients with systolic BP 150-220 mmHg without contraindications, acutely lower systolic BP to 140 mmHg—this is safe and improves functional outcomes 1. This represents the most recent high-quality evidence for BP targets in hemorrhagic stroke.
- Assess BP on initial arrival and every 15 minutes until stabilized 1
- Avoid antihypertensive agents that induce cerebral vasodilation (such as sodium nitroprusside) in patients with markedly elevated intracranial pressure 1
- Nicardipine is superior to labetalol for achieving and maintaining goal BP, with faster response time and fewer treatment failures 1
- Strictly avoid systolic BP <110 mmHg 2
Reversal of Coagulopathy
Anticoagulation must be discontinued immediately and reversed as soon as possible 2:
- For warfarin (INR ≥2.0): Administer 4-factor prothrombin complex concentrate (4F-PCC) over fresh frozen plasma, plus intravenous vitamin K to prevent re-emergence of anticoagulation 2
- Use FFP or 3F-PCC only when 4F-PCC is unavailable 2
- For heparin-related ICH: Administer protamine sulfate 2
- For direct oral anticoagulants: Use idarucizumab for dabigatran reversal; use andexanet alpha or 4F-PCC for factor Xa inhibitor reversal 2
- Patients with severe thrombocytopenia should receive platelet transfusion 1
Advanced Vascular Imaging
Obtain vascular imaging (CTA, MRA, or catheter angiography) to exclude underlying vascular lesions 1:
- Mandatory for lobar ICH in patients <70 years 2
- Mandatory for deep/posterior fossa ICH in patients <45 years 2
- Mandatory for deep/posterior fossa ICH in patients 45-70 years without hypertension history 2
- For spontaneous intraventricular hemorrhage without parenchymal hemorrhage, catheter angiography is required to exclude vascular anomaly 2
Monitoring and Care Setting
- Initial management must occur in ICU or dedicated stroke unit with physician and nursing neuroscience expertise 1
- Maintain nurse-patient ratio of 1:2 for first 24 hours, then 1:4 if stable 1
- Perform validated neurological scale assessment at baseline and repeat at least hourly for first 24 hours 1
- Initiate continuous cardiac monitoring for 24-72 hours to detect atrial fibrillation and arrhythmias 3
Management of Increased Intracranial Pressure
- Elevate head of bed 20-30 degrees to facilitate venous drainage 1
- Treat exacerbating factors: hypoxia, hypercarbia, hyperthermia 1
- For deteriorating patients with increased ICP: Consider osmotherapy (mannitol 0.25-0.5 g/kg IV over 20 minutes every 6 hours, maximum 2 g/kg) 1
- Hyperventilation can be used as temporizing measure for herniation syndromes 1
- Corticosteroids are NOT recommended for cerebral edema management 1
- For IVH with hydrocephalus causing decreased consciousness: External ventricular drainage is mandatory 2
- External ventricular drainage with intraventricular fibrinolysis promotes hematoma clearance, decreases mortality, and improves functional outcomes 1
Neurosurgical Intervention
Obtain prompt neurosurgical consultation for evaluation of potential surgical interventions 1:
- Cerebellar hemorrhage with neurological deterioration, brainstem compression, or hydrocephalus requires immediate surgical removal 1
- Consider early surgery for patients with Glasgow Coma Scale 9-12 1
- Surgical decompression recommended for large cerebellar infarctions causing brainstem compression and hydrocephalus 1
Seizure Management
- Treat new-onset seizures occurring within 24 hours with short-acting medications (e.g., lorazepam IV) if not self-limited 1
- Do NOT treat single, self-limiting seizures with long-term anticonvulsants 1
- Recurrent seizures should be treated as with any acute neurological condition 1
- Prophylactic anticonvulsants are NOT recommended for patients without seizures 1
Prevention of Complications
- Implement intermittent pneumatic compression for VTE prevention beginning day of admission 1
- Consider pharmacological VTE prophylaxis with UFH or LMWH after documenting hemorrhage stability on CT, typically 24-48 hours after ICH onset 1
- Do NOT use graduated compression stockings—they are less effective than intermittent pneumatic compression 1
- Perform formal dysphagia screening before initiating oral intake to reduce pneumonia risk 1
Fluid Management
- Avoid hypo-osmolar fluids (such as 5% dextrose in water) as they worsen cerebral edema 1
- Use isotonic saline 0.9% for fluid resuscitation 2
- Mild fluid restriction is recommended to help manage brain edema 1
Critical Pitfalls to Avoid
- Early deterioration is common: Over 20% of patients experience GCS decrease of ≥2 points between prehospital and ED evaluation 1
- Hematoma expansion occurs in 30-40% of patients within first hours and predicts poor outcome; risk factors include contrast extravasation ("spot sign"), early presentation, anticoagulant use, and large initial volume 1
- Do NOT delay imaging or treatment for diagnostic tests 1
- Hypotension must be corrected before transfer—persistent hypotension adversely affects neurological outcome 2
- For polytrauma patients with hemorrhagic brain injury, maintain SBP >100 mmHg or MAP >80 mmHg during interventions 2